Why is Eiko Lifescience falling/rising?

As of 28-Jul, Eiko Lifesciences Ltd is experiencing a decline in its stock price, currently at Rs 52.49, which represents a decrease of 1.0 or 1.87%. The stock has underperformed its sector today by 0.5% and has been on a consecutive downward trend for the last two days, resulting in a total decline of 3.69%. Additionally, the stock touched an intraday low of Rs 51.5 and has shown a significant drop in delivery volume, falling by 41.72% against the 5-day average. Over the past year, the stock has generated a return of -16.48%, while its profits have increased by 73%, indicating a disparity between stock performance and company profitability. Although promoters have increased their stake by 0.51%, signaling confidence in the company's future, the overall weak long-term fundamentals, including a low Return on Equity (ROE) of 2.6, contribute to the stock's negative movement.
In the broader market context, Eiko Lifesciences Ltd has underperformed compared to the Sensex, which has shown a decline of 1.59% over the past week, while Eiko's stock has fallen by 4.09%. The stock's year-to-date performance is notably poor, with a decline of 16.34%, contrasting sharply with the Sensex's gain of 3.52%. This underperformance in both short-term and long-term metrics highlights the challenges the company faces, despite some positive indicators such as rising promoter confidence and a fair valuation relative to peers. Overall, the combination of recent price declines, weak investor participation, and long-term fundamental weaknesses suggests a challenging environment for Eiko Lifesciences Ltd.